Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 11
Results: 6
Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 11, p. 829, doi. 10.1007/s40261-024-01397-5
- By:
- Publication type:
- Article
A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 11, p. 839, doi. 10.1007/s40261-024-01403-w
- By:
- Publication type:
- Article
Diagnosis and Management of Drug-Induced Interstitial Lung Disease in the context of Anti-Cancer Therapy: a Multidisciplinary Viewpoint by Portuguese Experts.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 11, p. 801, doi. 10.1007/s40261-024-01400-z
- By:
- Publication type:
- Article
Cost-Effectiveness of Empagliflozin (JARDIANCE<sup>®</sup>) in the Treatment of Patients with Chronic Kidney Disease in France, Based on the EMPA-KIDNEY Clinical Trial.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 11, p. 811, doi. 10.1007/s40261-024-01398-4
- By:
- Publication type:
- Article
Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes Mellitus.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 11, p. 849, doi. 10.1007/s40261-024-01405-8
- By:
- Publication type:
- Article
Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese Volunteers.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 11, p. 863, doi. 10.1007/s40261-024-01402-x
- By:
- Publication type:
- Article